Some hope for us re: Coronavirus?

[milkwoman]

Potential Pipeline Medications May Help Patients with Novel Coronavirus

pharmacytimes.com/news/pote...

Below is a bit of this article. It talks specifically about Remdesivir, Hydroxychloroquine, Umifenovir, Baloxavir, Favipiravir, Lopinavir and Ritonavir. (Click on the link above to read specifics on each of these medications).

I’m currently on hydroxychloroquine and while I’m very much practicing self-preservation protocols, I have to admit that this article makes me feel a bit better about the current pandemic situation as it relates to me personally.

_______________________________

Potential Pipeline Medications May Help Patients with Novel Coronavirus 2020-03-11 22:08:00

Marilyn Bulloch, PharmD, BCPS, FCCM

“It is important to note that there are currently no FDA-approved or even recommended agents for the treatment of the novel coronavirus (COVID-19), for which the World Health Organization (WHO) declared as pandemic on Wednesday. Any agent being used at this time is being administered in an experimental setting under controlled conditions. However, one of the fears of this virus is that there is no currently known treatment for it, and often it is the pharmacist that people look to first for information about medication developments.

In February 2020, the WHO published an overview of the potential therapeutic candidates for the treatment of COVID-19.1,2 The 36-page document outlines 76 regimens that have been proposed (as of February 17, 2020) for the treatment of patients infected with the virus. Thirty-eight of these candidates are in the preclinical state with minimal information available on their proposed mechanism, uses, doses routes, or planned trials. Sixteen of the remaining regimens contain an interferon-based product. The rest include a variety of antimicrobials, corticosteroids, convalescent plasma, and biologics.

Clinical trials of several other products not listed in the WHO document have been posted to ClinicalTrials.gov, and the Chinese government has released several versions of guidelines for the prevention, diagnosis, and treatment of the virus that includes specific medication recommendations.2 Some of the candidates are approved by the FDA for other indications, but the majority of the agents are not currently commercially available in the United States for therapeutic use.”